ArticleBlood advances2025
Bond DA, Switchenko JM, Villa D, et al. Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy. Blood Adv. 2021;5(23):5179-5189.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.